Related Experiment Videos
Revascularization for moyamoya disease: five-year follow-up
1Division of Neurosurgery, Northwestern University Medical School, Evanston, Illinois.
Surgical Neurology
|December 1, 1987
Summary
Moyamoya disease in a child was treated with encephaloduroarteriosynangiosis. Five-year follow-up showed clinical stabilization and intellectual development, with new blood vessels forming.
Area of Science:
- Neurology
- Pediatric Neurosurgery
- Vascular Neurology
Background:
- Moyamoya disease is a rare, progressive cerebrovascular disorder characterized by stenosis of the terminal internal carotid arteries and the development of collateral circulation.
- Severe moyamoya disease in pediatric patients presents significant challenges due to the risk of ischemic or hemorrhagic stroke.
- Early diagnosis and intervention are crucial for managing moyamoya disease in children to prevent neurological deficits.
Observation:
- A 4-year-old child with severe moyamoya disease affecting both anterior and posterior circulations was evaluated.
- The patient underwent encephaloduroarteriosynangiosis, a surgical procedure to improve cerebral blood flow.
- Serial angiography was performed over a 5-year follow-up period to monitor disease progression and treatment efficacy.
Findings:
- The surgical intervention led to early clinical stabilization in the pediatric patient.
- Despite pre-existing neurological deficits, the child demonstrated normal or superior intellectual development post-surgery.
- Follow-up angiography revealed the formation of significant direct anastomotic channels, indicating successful collateral development.
Implications:
- Encephaloduroarteriosynangiosis can be an effective treatment for severe moyamoya disease in children, promoting long-term clinical stability.
- The development of robust collateral circulation post-surgery supports favorable neurodevelopmental outcomes, even in the presence of early deficits.
- This case highlights the potential for surgical revascularization to alter the natural course of moyamoya disease and improve quality of life in affected children.